Monthly Archives July 2018

Click here to read the Pfizer notification of the reformulated Dilantin Capsules. There will be changes to both strengths at different periods. It is very important that you continue to purchase the existing product and only change once all stocks are depleted. Two reasons for this:- 1 – Once the patient has been switched to the new formulation they cannot…

As advised via PHARMAC tender of 30 April 2018 there is to be a change in the listing and future sole supply. New listings- from 1 July 2018 (HML only) Tranexamic-AFT Inj 100 mg per ml, 5 ml 5 ampoules                                                   Pharmacode 2497166          Schedule price $6.95 Incumbent brand Cyklokapron Inj 100 mg per ml, 5 ml 10  …

Click here to read the notification from Pfizer regarding the interruption to supply for the above mentioned product. ProPharma apologise for any inconvenience caused and confirm that we do have stock of the stronger strength 40 mg / ml 2 ml 10 Pharmacode 771740 We thank you in anticipation of your ongoing support.

Click here to access notification and acknowledgement form. Please action immediately. Stock can be returned to ProPharma/PWR along with a copy of the processed acknowledgement form for a full credit. Note this is one specific batch. We thank you in anticipation of your ongoing support.

Click here to read the notification from Douglas Pharmaceuticals regarding the future distribution route for the above mentioned product. All stock held in wholesale will be returned to Douglas on the last trading day of July 2018 without exception. As of the date of this notification ProPharma / PWR cannot accept Clopine Suspension  for credit under any circumstances. We apologise…

Click here to read notification from Apotex regarding supply issues and the alternative supply. Click here to read Pfizer notification relating to the alternative supply of Zithromax Tab 250 mg 6 (takes one back a long way) Please continue to order as usual and once stock of Apotex brand are delpleted we will automatically replace. Together we can make this…

The following products are being reference priced from 1 August 2018, which comes about from an alternative being award the Sole Supply within the next few months. We are highlighting these so that you have time to manage the transition. With price support from the suppliers ProPharma / PWR will be reducing the pricing to match the new subsidy from…

As advised via Pharmac Tender announcement 29 March 2018 there is to be a change in the listing and future sole supply. New listing from 1 August 2018 Bosentan  Dr Reddy’s Tab 62.5 mg 60            Pharmacode 2550067                   Schedule price $141.00 Bosentan  Dr Reddy’s Tab 125 mg 60             Pharmacode 2550075       Schedule price $141.00 Incumbent brand Bosentan-…

Close